Clinical Trials Directory

Trials / Completed

CompletedNCT04439474

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
187 (actual)
Sponsor
Baqiyatallah Medical Sciences University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3For up to 8 days, 50,000 units of vitamin D3 are given daily to patients in the first group so that the serum level of vitamin D reaches above 30 g / ml.
DRUGRoutine treatmentIn this group, patients receive their usual medications and treatments

Timeline

Start date
2018-10-10
Primary completion
2019-11-10
Completion
2020-02-10
First posted
2020-06-19
Last updated
2020-06-19

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT04439474. Inclusion in this directory is not an endorsement.